ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Additionally, adipocyte dysregulation is directly related to the development of steatohepatitis; this provides evidence to suggest that adiponectin is a good choice as a biomarker for both T2DM and NAFLD [43,44].